Phase II trial of tanespimycin (KOS-953), a heat shock protein-90 (Hsp90) inhibitor in patients with metastatic melanoma

被引:0
|
作者
Kefford, R.
Millward, M.
Hersey, P.
Brady, B.
Graham, M.
Johnson, R. G.
Hannah, A. L.
机构
[1] Westmead Hosp, Wentworthville, Australia
[2] Sir Charles Gairdner Hosp, Nedlands, WA, Australia
[3] Univ WA, Nedlands, WA, Australia
[4] Univ Newcastle, Newcastle, NSW, Australia
[5] Cabrini Hlth Private Hosp, Malvern, Australia
[6] Kosan Biosci, Hayward, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
8558
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage
    Park, Sangkyu
    Park, Jeong-A
    Jeon, Jae-Hyung
    Lee, Younghee
    BIOMOLECULES & THERAPEUTICS, 2019, 27 (05) : 423 - 434
  • [42] Heat Shock Protein 90 (Hsp90)-Inhibitor-Luminespib-Loaded-Protein-Based Nanoformulation for Cancer Therapy
    K. Rochani, Ankit
    Balasubramanian, Sivakumar
    Ravindran Girija, Aswathy
    Maekawa, Toru
    Kaushal, Gagan
    Kumar, D. Sakthi
    POLYMERS, 2020, 12 (08)
  • [43] AUY922, a Heat Shock Protein 90 (Hsp90) Inhibitor, Demonstrates Activity in Patients with Myeloproliferative Neoplasms (MPNs)
    Hobbs, Gabriella
    Litvin, Rivka
    Ahn, Jihae
    Mckenney, Anna Sophia
    Mauro, Michael J.
    Tallman, Martin S.
    Berman, Ellin
    Heaney, Mark Lawrence
    Levine, Ross L.
    Rampal, Raajit K.
    BLOOD, 2015, 126 (23)
  • [44] Phase II study of TAS-116, an oral inhibitor of heat shock protein 90 (HSP90), in metastatic or unresectable gastrointestinal stromal tumor refractory to imatinib, sunitinib and regorafenib
    Kurokawa, Y.
    Doi, T.
    Sawaki, A.
    Komatsu, Y.
    Ozaka, M.
    Takahashi, T.
    Naito, Y.
    Okubo, S.
    Nishida, T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [45] IDH1057, A novel, synthetic, small molecule inhibitor of heat shock protein 90(Hsp90)
    Kwon, Jin-Sun
    Moon, An-Na
    Park, Joon-Tae
    Hong, Soo-Jung
    Jeong, Jin-Ah
    Kwon, Sung-Wook
    Lee, Myong-Jae
    Jang, Hyeon-Soo
    Yeon, Seung-Woo
    Lee, Hong-Sub
    Kang, Jae-Hoon
    CANCER RESEARCH, 2012, 72
  • [46] Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-α (PPARα) and PPARβ activity
    Sumanasekera, WK
    Tien, ES
    Davis, JW
    Turpey, R
    Perdew, GH
    Vanden Heuvel, JP
    BIOCHEMISTRY, 2003, 42 (36) : 10726 - 10735
  • [47] A 124-amino acid peptide from secreted heat shock protein-90 (HSP90) is a novel wound repair agent
    Li, W.
    Cheng, C.
    Zhao, Z.
    Dai, J.
    Fan, J.
    Chen, M.
    Woodley, D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S4 - S4
  • [48] The decline of porcine sperm motility by geldanamycin, a specific inhibitor of heat-shock protein 90 (HSP90)
    Huang, SY
    Kuo, YH
    Tsou, HL
    Lee, YP
    King, YT
    Huang, HC
    Yang, PC
    Lee, WC
    THERIOGENOLOGY, 2000, 53 (05) : 1177 - 1184
  • [49] Role of heat shock protein 90 (HSP90) during heat stress in boar sperm
    Calle-Guisado, V.
    Hurtado de Llera, A.
    Bragado, M. J.
    Garcia-Marin, L. J.
    Gonzalez-Fernandez, L.
    REPRODUCTION IN DOMESTIC ANIMALS, 2017, 52 : 75 - 76
  • [50] Heat shock protein (HSP90) affects the replication of rotavirus
    Hu, Siman
    Tao, Xiao-Li
    Zhao, Wei
    Luo, Like
    Li, Runli
    Ma, Zhuping
    Sun, Lvyin
    Li, Yong-Gang
    FUTURE VIROLOGY, 2024, 19 (6-7) : 263 - 272